🔗 Permalink

Inventor profile of:

James E. BAILEY

City:

Zurich

Country:

Switzerland

Published Applications:

Last publication date:

2016-09-22

Top Assignees for applications by James E. BAILEY

The entities that hold a legal rights for patent applications filed by inventor BAILEY James E.:

ROCHE GLYCART AG 5 SCHLIEREN-ZURICH, Switzerland
Roche GlycArt AG 3 , Switzerland
Roche GlycArt AG 3 Zurich, Switzerland
GlycArt Biotechnology AG 2 Schlieren-Zurich, Switzerland
GlycArt Biotechnology AG 2 Zurich, Switzerland
Roche GlycArt AG 1 Switzerland, Germany
GlycArt Biotechnology AG 1 Schlieren-Zürich, -
Roche GlyeArt AG 1 , Switzerland
ROCHE GLYCART AG 1 Schlieren, Switzerland

Recent patent applications by BAILEY James E.

James E. BAILEY from Zurich, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2016-09-22

US20160272719A1

Chemistry; metallurgy

Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity

#2 | 2015-10-01

US20150274837A1

Chemistry; metallurgy

Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity

#3 | 2012-05-17

US20120122206A1

Chemistry; metallurgy

Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity

#4 | 2011-12-01

US20110294984A1

Chemistry; metallurgy

Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity

#5 | 2011-12-01

US20110293609A1

Human necessities

Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity

#6 | 2011-06-16

US20110142825A1

Chemistry; metallurgy

Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity

#7 | 2011-03-15

US10437388

Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity

#8 | 2009-12-10

US20090304690A1

Chemistry; metallurgy

Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity

#9 | 2008-11-13

US20080280322A9

Human necessities

Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity

#10 | 2005-12-08

US20050272128A1

Human necessities

Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity

#11 | 2005-04-14

US20050079605A1

Chemistry; metallurgy

Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity

#12 | 2005-04-07

US20050074843A1

Chemistry; metallurgy

Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity

InventorID:

1304015 ⎘